RYTM (NASDAQ: RYTM) brokered notice for 35,460-share sale on 03/03/2026
Rhea-AI Filing Summary
RYTM proposed sale of 35,460 common shares on 03/03/2026. The filing lists 35,460 shares tied to an exercise of options under a registered plan and an aggregate value of $3,209,778.92 on 03/03/2026. The transaction is reported through Morgan Stanley Smith Barney LLC on NASDAQ.
Positive
- None.
Negative
- None.
Insights
Routine Form 144 sale notice tied to option exercise; limited immediate market impact.
The filing lists 35,460 shares proposed for sale following an exercise of options under a registered plan on 03/03/2026 with an aggregate value of $3,209,778.92. This is a notification of intent to sell under Rule 144 rather than an executed open‑market transaction.
Price and execution timing are not provided; market impact depends on how and when the shares are sold and on existing float. Subsequent transaction reports or broker disclosures will specify execution details.
Sale originates from option exercise under a registered plan; administrative disclosure.
The entry names Morgan Stanley Smith Barney LLC as the broker for the proposed sale of 35,460 shares on 03/03/2026. The method cites an exercise of options under a registered plan, indicating shares became available through a plan process.
Share disposition mechanics and any beneficial‑ownership changes are not shown here; further SEC reports may confirm final sale amounts and any resulting ownership changes.